Cleared Traditional

K821202 - HEMOGLOBIN REAGENT SET

K821202 is an FDA 510(k) clearance for HEMOGLOBIN REAGENT SET, manufactured by Omega Medical Electronics. The device is a Class 2 Hematology device with product code GKK cleared through the Traditional 510(k) pathway after a 27-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1982
Decision
27d
Days
Class 2
Risk

K821202 is an FDA 510(k) clearance for the HEMOGLOBIN REAGENT SET. Classified as Cyanomethemoglobin (product code GKK), Class II - Special Controls.

Submitted by Omega Medical Electronics (Mchenry, US). The FDA issued a Cleared decision on May 24, 1982 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7500 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K821202

510(k) Number K821202 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 27, 1982
Decision Date May 24, 1982
Days to Decision 27 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
86d faster than avg
Panel avg: 113d · This submission: 27d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKK Device Classification - Class 2, Special Controls

Product Code GKK Cyanomethemoglobin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7500
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKK Cyanomethemoglobin

Devices cleared under the same product code (GKK) and FDA review panel - the closest regulatory comparables to K821202.
RAICHEM TM HEMOGLOBIN REAGENT
K896922 · Reagents Applications, Inc. · Jan 1990
MODIFIED HEMOGLOBIN REAGENT SET
K894951 · Macomb Biotechnology, Inc. · Oct 1989
KVM PREPACK HEMATOLOGY REAGENT SET
K883992 · Kvm Technologies, Inc. · Oct 1988
CYMET-PLUS
K771716 · J.T. Baker Chemical Co. · Sep 1977
UNIPAK HEMOGLOBIN
K771090 · Harleco · Jul 1977
HEMOTOLOGY PRODU&TS (5 IN ALL)
K770803 · Hycel, Inc. · Jul 1977